We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
Abcuro, a biotechnology company in the clinical stage, focused on developing therapies that target autoimmune diseases and cancer via precise adjustments to cytotoxic T and NK cells, has
CytoMed Therapeutics, headquartered in Singapore, has entered into a Memorandum of Understanding (MOU) with Hangzhou CNK Therapeutics (CNK) to boost its allogeneic CAR γδ T in vivo persistency.
Gritstone bio, a biotechnology company in the clinical stage, has entered into an agreement with Genevant Sciences, a company specialising in nucleic acid delivery. As per the agreement
Antengene, a commercial-stage global biopharmaceutical company, and Hansoh Pharmaceutical Group Company have collaborated for the commercialisation of Antengene’s product Xpovio within mainland China. Xpovio, designed to treat adult
Regeneron Pharmaceuticals has announced its intention to purchase Decibel Therapeutics, a biotechnology company in the clinical stage, in a transaction valued at roughly $109m. Decibel Therapeutics is focused
ADARx Pharmaceuticals, a biotechnology company in the clinical stage that specialises in developing advanced RNA therapeutics, has announced the successful conclusion of an oversubscribed Series C financing round,
Aspen Neuroscience has received clearance from the US Food and Drug Administration (FDA) for its Investigational New Drug (IND) application, which allows the company to move forward with
Ginkgo Bioworks, a company at the forefront of cell programming and biosecurity, has unveiled a fresh partnership with Merck, recognised as MSD beyond the borders of the US
Ionis Pharmaceuticals and Novartis have joined hands in a collaboration and license agreement aimed at discovering, developing, and bringing to market an innovative medicine designed specifically for patients
FACIT (Fight Against Cancer Innovation Trust) and the University of Toronto’s Temerty Centre for Artificial Intelligence Research and Education in Medicine (T-CAIREM) have joined forces in a partnership